CLINFAST
DEAD

Serial Number

98856865

Owner

Selkirk Pharma

Attorney

Rhett V. Barney

Filing Date

Nov 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CLINFAST Trademark

Serial Number: 98856865

CLINFAST is a trademark filed by Selkirk Pharma on November 15, 2024. The trademark is classified under Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Selkirk Pharma (4 trademarks)

827 W. First Ave. Suite 401
Spokane, WA 99201

Entity Type: 03

Trademark Details

Filing Date

November 15, 2024

Registration Date

Not Registered

Goods & Services

Manufacturing services for others in the fields of biotechnology and pharmaceuticals; Manufacturing services for others of pharmaceuticals, medicines, medicaments, and the packaging for same; Custom production and processing of chemicals, ingredients for pharmaceuticals, and cells for research and scientific purposes for others; Manufacture of bacteriological cultures, buffer solution, and reagents to the order and specification of others; Custom manufacture of pharmaceuticals, medicines and medical therapies

Merchandise packaging for others; Merchandise packaging, namely, packaging of pharmaceuticals, medicines, medicaments, veterinary products for others

Development of pharmaceutical preparations and medicines; Product development in the fields of biotechnology and pharmaceuticals; Product development consulting in the fields of biotechnology and pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of biotechnology and pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development services; Pharmaceutical research and development; Scientific laboratory services; Scientific and technological services, namely, scientific research in the field of biotechnology and pharmaceuticals; Research and development of new products for others; Product development consultation; Product research and development; Scientific research and development; Design and testing for new product development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 30, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2025 CNRT
ASSIGNED TO EXAMINER
May 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 15, 2024 NWAP